drugset / Trial / NCT01882816

Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Non-Anaplastic Non-Medullary Thyroid Cancer

NCT01882816 ↗

Phase 2 Completed 27 enrolled Memorial Sloan Kettering Cancer Center
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this Phase 2 study is to find out what effect, good and/or bad, external beam radiation therapy, has on the patient and their thyroid cancer where surgery is not an option or where despite surgery, the disease is still present.

Timeline

Start
2013-06-13
Primary completion
2021-11-04
Completion
2021-11-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Doxorubicin Other / unclassified 10 mg/m2 —